Patentable Subject Matter in the Health Sciences:
Diagnostics & DNA

Berkeley Center for Law and Technology

4/5/2012

Intellectual Property Litigation, Patent Counseling + Prosecution, and Patent Litigation

University of California School of Law
Warren Room
215 Boalt Hall
Berkeley, CA 94720

Janet Xiao

Janet Xiao

Speaking Engagement

BCLT will host a panel discussion of issues of great importance to healthcare and biotechnology: the patentabilty of Diagnostic methods and DNA. The discussion will focus on the doctrinal and societal implications of two current cases: Prometheus v Mayo and AMP v Myriad.

In the recent Prometheus case, the US Supreme Court held that a claim that covers specific correlations between blood test results and patient health is not eligible for patent protection.

In the Myriad case, a pending petition for certiorari seeks Supreme Court review of the Federal Circuit decision overturning a summary judgment ruling that various claims to DNA lack patent-eligibility.

Janet Xiao will join the program panel.

2.0 hours of CLE will be available to attendees.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2018 Morrison & Foerster LLP. All rights reserved.